Oncologix Tech Inc. | Cash Flow

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
653.50
1,407.60
2,553.00
1,849.50
2,370.60
Depreciation, Depletion & Amortization
5.60
22.80
19.20
16.60
14.90
Other Funds
-
-
515.40
386.90
-
Funds from Operations
492.40
352.60
848.30
492.20
2,090.20
Changes in Working Capital
639.50
277.40
491.80
837.10
2,066.00
Net Operating Cash Flow
147.10
629.90
356.50
344.90
24.20
Capital Expenditures
-
0.90
3.30
-
0.90
Sale of Fixed Assets & Businesses
-
8.60
-
-
-
Net Investing Cash Flow
324.10
67.20
564.20
-
0.90
Issuance/Reduction of Debt, Net
108.60
665.20
1,443.70
77.10
4.20
Net Financing Cash Flow
214.60
675.20
928.30
309.70
4.20
Net Change in Cash
37.50
22.00
7.50
35.20
29.40
Free Cash Flow
147.10
630.80
359.80
344.90
25.10
Net Assets from Acquisitions
324.10
75.00
561.00
-
-
Change in Capital Stock
106.00
10.00
-
-
-

About Oncologix Tech

View Profile
Address
1604 West Pinhook Road
Lafayette Louisiana 70508
United States
Employees -
Website http://www.oclghealth.com
Updated 07/08/2019
Oncologix Tech, Inc. is a medical holding company, which is engaged in the operation and manufacture of medical device products. It operates through three segments: Personal Care Services, Medical Device Manufacturing, and Medical Products Distribution & Technologies. The Personal Care Services segment provides non-medical, personal care attendant services, supervised independent living, long-Term senior care, and other approved programs.